TIMP2 and neoplasm: miR-130b also acts as an oncogenic miRNA as its upregulation leads to the decreased expression of tissue inhibitor of metalloproteinase-2 (TIMP-2), which leads to increased activity in matrix metallopeptidase 2 and enhanced tumor metastasis [97].